Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples